Peripancreatic pseudoaneurysms: a management-based classification system by unknown
Peripancreatic pseudoaneurysms: a management-based
classification system
Tony C. Y. Pang • Richard Maher •
Sivakumar Gananadha • Thomas J. Hugh •
Jaswinder S. Samra
Received: 15 September 2013 / Accepted: 9 January 2014 / Published online: 12 February 2014
 The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract
Background Peripancreatic pseudoaneurysms can arise in
a number of different clinical settings but are associated
mostly with pancreatitis and pancreatobiliary surgery. The
aim of this study is to review the current literature and to
propose a management classification system based on the
pathophysiological processes and the exact anatomical site
of peripancreatic pseudoaneurysms.
Methods A systematic review of the literature from 1995
to 2012 was performed. Articles on studies describing
peripancreatic pseudoaneurysms in the setting of pancrea-
titis or major hepatic or pancreatic surgery with more than
ten patients were included. Seventeen eligible studies were
identified and reviewed.
Results The demographic characteristics of the patients in
all studies were similar with a predominance of males and a
mean age of 55 years. The overall mortality rate varied
greatly among the studies, ranging from 0 to 60 %. Em-
bolisation was the first line of management in the majority
of the studies, with surgery reserved for failed embolisation
or for haemodynamically unstable cases. Embolisation of
the hepatic artery or its branches was associated with high
rates of morbidity (56 %) and hepatic failure (19 %). More
recent studies show that stents are used increasingly for
vessels that cannot be embolised safely. Late bleeding, a
major cause of mortality and morbidity, is generally un-
derreported. The proposed classification system is based on
three factors: (1) the type of artery from which the pseu-
doaneurysm arises, (2) whether communication with the
gastrointestinal tract is present, and (3) whether there is
high concentration of pancreatic juice at the bleeding site.
Conclusion The management of peripancreatic pseud-
oaneurysms usually comprises a combination of interven-
tional radiology and surgery and this may be assisted by a
logical classification system.
Keywords Pseudoaneurysm  Pancreatoduodenectomy 
Chronic pancreatitis  Acute pancreatitis
Managing peripancreatic pseudoaneurysms is complex and
challenging. Advances in imaging technology and inter-
ventional radiology have had an enormous impact on both
the diagnosis and the treatment of this condition. Pseud-
oaneurysms can arise in a number of different clinical
settings but are associated mostly with pancreatitis and
pancreatobiliary surgery [1].
Initially, the high mortality associated with this condition
is due to uncontrolled torrential bleeding. If the patient
survives this initial phase there is a risk of rebleeding, which
can occur from days to years after the initial presentation.
The additional late mortality may be substantial if patients
are not managed appropriately during their initial presen-
tation. Treatment strategies should be based on the mech-
anisms that lead to the formation of pseudoaneurysms and
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and Other Interventional Techniques 
to the ongoing pathophysiological processes that result in
rebleeding.
Currently, the best method of assessing a relatively
stable patient is a computerised tomography (CT) angio-
gram with or without a formal angiogram [2]. This usually
provides an accurate diagnosis but also allows, if required,
radiological intervention by embolisation of the feeding
vessel or the pseudoaneurysm itself. If visceral ischaemia
distal to the pseudoaneurysm is a concern, a stent may be
placed [1, 3]. Patients with haemodynamic instability may
need immediate surgical intervention, although this can be
fraught with danger even in experienced hands.
There are no data on definitive long-term management
strategies for this condition. This is partly due to its low
rate of occurrence but also because of a poor understanding
of the pathophysiological processes involved. The mecha-
nisms by which most peripancreatic pseudoaneurysms are
formed are thought to be related to the underlying
inflammation, the presence of pancreatic juices, and the
subsequent infection [4]. In postoperative patients, pseud-
oaneurysms are often associated with intra-abdominal
sepsis due to anastomotic leakage [5]. Unless these
underlying processes are dealt with adequately, the risk of
further bleeding can be substantial.
The aim of this article is to review the literature
regarding pancreatic pseudoaneurysms with an emphasis
on current treatment practices. We also propose a man-
agement classification system based on the pathophysio-
logical processes and the exact anatomical site of the
pseudoaneurysm. A classification such as this may help
with decision making during initial and definitive man-




A literature search was performed using ‘‘keywords’’ and
‘‘headings’’ in Medline and EMBASE limited to publica-
tions from 1995 to 2011. Keyword searches of panc*,
surg*, resect*, and neoplasm* and heading searches of
pseudoaneurysm, pancreatitis, operation, cancer, and neo-
plasm were used along with Boolean operators.
Due to the variability of the descriptions of peripan-
creatic arterial haemorrhagic complications, articles were
eligible only if they included patients with peripancreatic
pseudoaneurysms, ‘‘aneurysms,’’ or peripancreatic arterial
bleeding detected on angiography. Non-English articles,
single case reports, case series with fewer than ten patients
(even if more than ten pseudoaneurysms were treated), and
reviews were excluded. Case series with patients with
mixed pathologies (e.g., haemosuccus pancreaticus, sus-
pected pancreatic bleeding with no definitive angiographic
findings [6], or delayed postpancreatectomy haemorrhage)
were included only if adequate clinical information about
patients with the above eligible pathology could be
extracted or if patients were selected such that only those
with visceral arterial bleeding was included. Articles
describing visceral pseudoaneurysms that were not asso-
ciated with pancreatitis or pancreatobiliary surgery (e.g.,
vasculitis) were also excluded [7].
Twenty studies were identified during the initial litera-
ture search and 17 met the eligibility criteria. Two pairs of
studies were most likely from the same institution and
therefore only the more recent study was included in the
analysis [8, 9]. One additional study was excluded due to
insufficient information [10].
Statistical analysis
All statistical analyses and charting were performed with
Microsoft Excel 2010 for Windows (Microsoft Corp.,
Redmond, WA) and Stata SE version 11.2 for Windows
(StataCorp., College Station, TX). Due to the heterogeneity
of the patient population and the treatment strategies, no
inferential statistical analyses were performed. Only
descriptive statistical analyses are presented and discussed.
Results and discussion
Pancreatic pseudoaneurysms are relatively rare and the
exact incidence is difficult to measure due to the varying
aetiologies. The most common associations are with pan-
creatitis and major pancreatobiliary surgery. The relative
incidence of these two aetiologies is not clear because a
significant number of studies present either type but not
both. Pseudoaneurysms can occur in both acute and chronic
pancreatitis; however, they are more common in chronic
pancreatitis and are often associated with pseudocysts [11].
It is thought that pancreatic juice within the pseudocyst
causes enzymatic degradation of the adjacent arterial wall,
with weakness and rupture leading to pseudoaneurysm
formation. In the setting of major pancreatobiliary surgery,
pseudoaneurysm formation is thought to be associated with
either skeletonisation of vessels or complicating bilio- or
pancreaticoenteric anastomotic leak [5, 12, 13].
The studies reviewed are listed in Table 1. The demo-
graphic characteristics of the patients in all studies were
similar, with a predominance of males and a mean age 55
(45–66) years (excluding the studies De Perrot et al. [14]
and Lee [15]). The mean age of the surgical patients who
developed pseudoaneurysms was older than that of the
patients with pancreatitis (range of means: 58–66 vs.
2028 Surg Endosc (2014) 28:2027–2038
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Table 1 Demographic and mortality data
















14 0 14 1985–1998 60 (40–72) 11:3 10 (71) 4 (29) – 10 (71) 11 (79) 4 (29)
Fujii et al.
[12]
13 0 13 1993–2005 66 (SD 10) 10:3 – – – – – 7 (54)
Miura et al.
[5]
15 0 15 1981–2007 65 (50–82) 11:4 – – – – 7 (47) 9 (60)
Lee [15] 27 0 27 1995–2007 – – 13 (48) 10
(37)
6 (22) – 21 (78) 6 (22)
Scha¨fer et al.
[30]
18 0 18 1998–2009 58 (39–82) 11:7 4 (22) 7 (39) 9 (50) 2 (11) – 6 (33)
Lee et al.
[31]
27 0 27 2003–2011 64 (48–86) 20:7 20 (74) 13
(48)




0 14 14 1983–1994 46 (32–60) 11:3 2 (14) 8 (57) 4 (29) – N/A 2 (14)
De Perrot
et al. [14]
0 10 10 1978–1997 44 (med)
(28–61)





0 16 16 1988–1998 45 (23–67) 11:5 – – – – N/A 3 (19)
Beattie et al.
[23]
0 13 h 13 1995–1999 57 (25–81) 11:8 – – – – N/A 3 (21)
Bergert et al.
[11]







0 19 19 2000–2003 43 (26–61) 10:9 – – 5 (26) – – –
Lermite et al.
[16]
0 17 17 1981–2005 57 (35–70) 15:2 – 13
(76)
2 (12) 2 (12) N/A 0 (0)
Udd et al.
[25]
0 33 33 1993–2005 54 (42–78) 27:6 – 17
(52)
– 22 (67) N/A 2 (6)
Sethi et al.
[27]
0 16 16 2000–2007 52 (21–71) 11:5 2 (13) 8 (50) 10 (63) 14 (88) N/A 0 (0)
Both pancreatitis and postoperative
Zyromski
et al. [3]




21:16 7 (19) 14
(38)







9 12 23i 1978–2010 64 (21–84) 17:6 19 (83) 2 (9) 2 (9) – 6 (26)
GI gastrointestinal, N/A not applicable, Pancr pancreatitis, Postop postoperative, SD standard deviation, – no data, med median
a Values are number (n)
b Values are mean (range)
c Values are number (percent)
d Intra-abdominal bleed includes bleeding from drain as presenting symptom and massive distention
e Gastrointestinal bleed includes haematemesis, melaena, and haematochezia
f Occult/shock is no obvious presenting symptoms apart from signs of blood loss, either acute or chronic (shock, anaemia)
g Mortality is 30-day or inpatient all-cause mortality
h Article described 19 patients, but only 13 demonstrated angiographic evidence of bleeding or pseudoaneurysm (1 vasculitis, 5 negative angiograms).
Age and sex distribution based upon the entire 19 patients described in the paper
i Two patients were secondary to trauma
j Kalva et al’s study described 51 patients, but only 23 patients demonstrated a pseudoaneurysm or evidence of active extravasation
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44–57 years). Interestingly, young patients (\40 years)
were almost exclusively in the pancreatitis group. This age
difference was confirmed by Zyromski et al. [3]; theirs was
the only study that compared these two patient groups
(mean age = 62 vs. 46, P \ 0.007).
Presentation and outcome
Pseudoaneurysms may rupture into the gastrointestinal
tract (GIT), the peritoneal cavity, the pancreatic duct, or a
pseudocyst. Bleeding into the GIT can occur directly or
indirectly. The latter is often due to haemosuccus pancre-
aticus or haemobilia [3, 16], where patients present with
haematemesis, haematochezia, or melaena. Those with
extensive retroperitoneal haematoma, but without bleeding
into the GIT, may present with pain only. In the studies
reviewed, gastrointestinal bleeding was the most common
presentation overall. In postoperative patients, intra-
abdominal bleeding was the most common presentation,
reflecting the underlying pathophysiology. On the other
hand, in patients with pancreatitis, pain was the most
prominent presenting symptom (Table 1).
The onset of fresh bleeding from a drain following
pancreatic surgery is an ominous sign suggestive of intra-
abdominal bleeding, including from a pseudoaneurysm. It
is known as a sentinel bleed. Initial minor bleeding may be
followed by more catastrophic blood loss and this occurs in
up to 90 % of cases [5, 15]. The importance of a sentinel
bleed was first highlighted by Sato et al. [17] who descri-
bed it in all ten patients in their study with massive
bleeding following pancreatectomy. More recent studies
also suggested that this is frequently a warning sign of
imminent and massive haemorrhage after pancreaticobil-
iary surgery [18, 19]. Early angiography is recommended
as this may allow intervention while the patient is still
haemodynamically stable. On the other hand, some authors
have found that despite awareness of this entity, identifi-
cation of a sentinel bleed was not associated with a sig-
nificant difference in mortality [20]. Unfortunately, it is
unclear from this latter study whether specific interventions
were undertaken in response to the bleeding. Overall,
sentinel bleeding was noted in 47–92 % of patients in the
studies reviewed (Table 1).
The overall mortality rate in patients with bleeding
peripancreatic pseudoaneurysms varied greatly among the
studies, ranging from 0 to 60 %. The mortality rate for
bleeding associated with pancreatitis (0–21 %) was lower
compared with that for bleeding post-surgery (22–60 %).
Unfortunately, few studies included patients from both
groups, which prevented meaningful inferential statistical
analysis. The study by Zyromski et al. [3] was the only one
that compared the two groups and, indeed, found a statis-
tically significant difference in mortality favouring the
pancreatitis group (31 % vs. 4 %, P = 0.04). In the post-
pancreatitis group, there was a trend toward improvements
in mortality, with the most recent studies reporting mor-
tality rates of less than 10 %. This compares favourably
with historical mortality rates (up to 30 %) for patients who
underwent operative intervention for postpancreatitis
pseudoaneurysms [21, 22].
Treatment strategies
Initial control of the pseudoaneurysm or any active
bleeding may be achieved radiologically or surgically. The
range of surgical and nonsurgical treatment options and
outcomes is summarised in Tables 2 and 3. In studies that
did not select patients based on treatment strategy, em-
bolisation was the first line of management in the majority
of them published after 2000 (46–92 %) [3, 11]. While
some authors preferred angiography (with or without em-
bolisation) as the initial management option [1, 23], others
were more selective depending on the presentation [24].
This may be a reflection of local expertise and resource
availability.
In postoperative studies, mortality rates in the surgical
group were generally higher (50–100 %) than those in the
embolisation group (13–50 %). However, this might be
expected given that patients requiring early surgical inter-
vention are usually more haemodynamically unstable than
those who can wait for angiography.
In the pancreatitis studies, outcomes for surgical and
nonsurgical intervention were similar except in the earlier
studies. Specifically, the study by De Perrot et al. [14],
published in 1999, stood out in that it demonstrated a high
mortality rate in patients who were embolised (33 %)
compared with a zero mortality rate for the surgical
patients. This may reflect relative inexperience with em-
bolisation techniques at a time when surgical therapy was
the standard approach.
Obviously, patient selection and timing play important
roles in determining the morbidity and mortality of either
procedure. Bergert et al. [11] demonstrated this by dividing
their patients into those requiring urgent and those requir-
ing semiurgent intervention. Three of nine (33 %) urgent
surgical patients died compared with only one of ten
(10 %) semiurgent patients. Herein lies the difficulty in
comparing outcomes of surgical and embolisation groups
in these case series where the indications and underlying
pathologies for embolisation and surgery may be different.
This makes statistical comparisons between the outcomes
of these two modalities difficult and probably unnecessary.
Nonetheless, some authors have attempted statistical
analyses. For example, Udd et al. [25], in a series of 33
pseudoaneurysmal bleeds from chronic pancreatitis, found
no difference in morbidity and mortality between the
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embolisation and surgical groups. Similarly, Roulin et al.
[26] performed a meta-analysis comparing laparotomy and
interventional radiology for delayed postoperative haem-
orrhage following pancreatic surgery and, not surprisingly,
found a higher mortality rate in the surgical group.
The overall reported success rates of embolisation are
high, but this often includes multiple embolisations as well
as prolonged supportive treatment. As a single procedure,
embolisation alone has a substantial failure rate. The pri-
mary failure rate in the studies reviewed ranged from 0 to
50 %, with a rebleeding rate of 0–38 % (Table 2). Overall,
this translates into a total failure rate of between 6 and
55 %, with half of the studies (median of all studies)
having a failure rate of greater than 23 %. Of the combined
262 patients embolised or stented in all reviewed studies,
51 required a secondary procedure (either re-embolisation
or surgery).
Although embolisation was used as first line treatment in
most of the recent studies, surgery still remains an
important treatment modality, especially in the setting of a
haemodynamically compromised patient or when angio-
graphic management fails. The low operation rates in some
studies suggest that haemodynamically compromised
patients may still be treated radiologically at first [3, 13, 15,
27]. For this to work optimally, the initial radiological
intervention should be carried out in an angio-theatre suite,
so if it fails, immediate surgical intervention is possible.
Other indications for surgery included situations where
access to the bleeding vessel was impossible radiologically
and when there was failed visualisation or failed emboli-
sation of the bleeding vessel for definitive management of
the underlying cause or for other coexisting abdominal
pathologies [3, 25, 27]. The indications and outcomes of
operative management in the studies reviewed are sum-
marised in Table 3.
The use of stents is a third treatment modality that is
being used increasingly for visceral pseudoaneurysms [28,
29]. A stent has the advantage of excluding the pseudo-
aneurysm while allowing continued flow through the
feeding vessel. Only four of the case series reviewed used
stents to achieve haemostasis. Lee [15] placed stents in
both the common hepatic artery (CHA) (for a short gas-
troduodenal stump pseudoaneurysm) and the superior
mesenteric artery (SMA) in an attempt to avoid end organ
ischaemia. Zyromski et al. [3] placed a stent in one patient,
but it is unclear in which vessel or the specific indication.
The two most recent studies reviewed [30, 31] employed
arterial stents as primary intervention for 15 and 17 % of
patients, respectively. However, no details were given as to
which vessel was stented or the indications. Satisfactory
results with stents have been reported by small selective
case series. Herzog et al. [29] reported four patients in
whom successful haemostasis was achieved with covered
stents used for delayed visceral haemorrhage following
pancreatic surgery. Similarly, successful haemostasis was
achieved in all patients in two smaller case series of four
and five patients with hepatic arterial bleeding [28, 32].
Visceral artery stent placement, however, is not without
potential complications. The long-term patency and clini-
cal outcomes of stents in this setting are not known [32].
Some authors argue that stent occlusion from intimal
hyperplasia may not affect long-term outcome given that it
is a slow process which allows time for the formation of
collaterals [33]. Such collateralisation did not develop in a
patient reported by Lee [15]. The patient developed major
thrombosis of the SMA after stent placement resulting in
long-term parenteral nutrition due to short-gut syndrome.
Other disadvantages of this technique include the possi-
bility of stent infection, exclusion of branches close to the
pseudoaneurysm, kinking or misplacement of the stent, and
arterial rupture during placement. The lack of availability
of small visceral artery ‘‘covered’’ stents may also be a
limitation to this approach [5]. The potential complication
of stent infection [34] is a major concern in this setting
where frequently there is communication with the GIT or
the presence of infected necrotic tissue (e.g., necrotising
pancreatitis). Infection of a foreign body, such as a stent,
may become chronic due to ongoing contamination from
an uncontrolled gastrointestinal anastomotic leak. This may
be exacerbated if there is a pancreatic anastomotic break-
down where the digestive enzymes contribute to the deg-
radative process.
Influence of vessel type on treatment strategy
The distribution of involved arteries in each study is
summarised in Table 4. As expected, pancreatitis-related
pseudoaneurysm formation and bleeding involve most
commonly either the splenic artery or the gastroduodenal/
pancreaticoduodenal arterial complex. Post pancreatic
surgery cases can affect the same vessels, but the hepatic
and mesenteric arteries may also be at risk as a result of an
anastomotic leak or an operative injury during radical
lymphadenectomy. Unfortunately, it is impossible to glean
from the reviewed studies the exact cause of the bleeding
and its relationship to arterial distribution.
Splenic, gastroduodenal, and pancreaticoduodenal
arteries were the most commonly involved vessels in the
studies reviewed. Embolisation of the splenic artery was
relatively safe, with only four patients reported to have
suffered splenic infarction with infective complications [1,
3]. Also, there were no definite ischaemic complications
reported for GDA/PDA (gastroduodenal artery/pancreati-
coduodenal artery) embolisation. In a post pancreatoduo-
denectomy patient, pseudoaneurysm formation in a short
GDA stump can be a difficult problem to treat with end
2032 Surg Endosc (2014) 28:2027–2038
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embolisation alone. Hur et al. [35] demonstrated a high rate
of rebleeding following the embolisation of the GDA
stump and pseudoaneurysm. Even when the CHA also was
embolised proximal and distal to the GDA stump, the risk
of further bleeding remained significant.
This raises the issue of the safety of embolisation of the
CHA and vessels distal to it. Hur et al. [35] found a high
incidence of hepatic infarction (3/16, 19 %) with this
procedure. Although they were able to manage all their
cases conservatively, outcomes following embolisation of
the hepatic arteries were not as favourable in the other
studies reviewed. In the few studies where specific details
of the embolised vessels and the clinical outcomes were
available, a total of 26 proper hepatic artery (PHA)/CHA
and 10 right/left/middle hepatic artery (R/L/MHA) em-
bolisations were reported [3, 5, 12, 13, 15, 27]. In those
patients, there were seven instances of hepatic failure (of
which six died), ten with hepatic infarction and three with a
liver abscess. Overall, the morbidity rate was 56 % and the
hepatic failure rate of 19 %. In another recent study of
hepatic artery embolisation, 23 % (6/26) of patients
developed liver infarction or an abscess. Sato et al. [36]
also reported a high morbidity rate (45 %), hepatic failure
rate (47 %), and mortality rate (30 %) following hepatic
artery embolisation for bleeding after major pancreatic and
hepatic surgery. These authors stress the importance of
collateral vessel formation requiring multiple embolisa-
tions, which increases the risk of fatal complications.
Pseudoaneurysms arising from the SMA are uncommon.
These can be managed operatively or by radiological
placement of a stent. Miura et al. [5] reported a single case
of coil embolisation of an SMA pseudoaneurysm where
they managed to maintain patency of the SMA. Unfortu-
nately, the patient subsequently rebled and died. Lee [15]
described a patient in whom a SMA stent resulted in
thrombosis and the ensuing intestinal ischaemia caused the
patient to be dependent on parenteral nutrition. Two cases
of SMA pseudoaneurysmal bleeding treated by stent
deployment demonstrated control of the bleeding, although
one patient died from sepsis due to chronic stent infection
Table 3 Surgical treatments and outcomes
Surgical management
A Surgery Indication Failure Rebleed Secondary treatment Death
I J K M
n n (% A) Emer Techa Isch Other n (% I) n (% I) Emb Sten Sur No n (% I)
Postoperative only
Okuno et al. [13] 14 1 (7) 1 0 (0) 0 (0) 1 (100)
Fujii et al. [12] 13 3 (23) 1 2 0 (0) 0 (0) 2 (66)
Miura et al. [5] 15 3 (20) 2 1 1 (33) 0 (0) 1 3 (100)
Lee [15] 27 2 (7) 2 0 (0) 1 (50) 1 1 (50)
Scha¨fer et al. [30] 18 6 (39) 2 4 1 (17) 3 (50)b 4 (67)
Lee et al. [31] 27 1 (4) 1 0 (0) 0 (0) 1 (100)
Pancreatitis only
Gambiez et al. [37] 14 0 (0) – – –
De Perrot et al. [14] 10 7 (70) 3 4c 0 (0) 0 (0) 0 (0)
Carr et al. [38] 16 10 (63) 6 4 3 (30) 1 (10) 4 3 (30)
Beattie et al. [23] 13 4 (31) 3 1 0 (0) 0 (0) 0 (0)
Bergert et al. [11] 35 19 (54) 9 10 3 (16) 4 (21) No data 4 (21)
Zhou et al. [40] 19 0 (0) – – –
Lermite et al. [16] 17 7 (41) 7 0 (0) 0 (0) 0 (0)
Udd et al. [25] 33 10 (30) 10 0 (0) 1 (10) 1 1 (10)
Sethi et al. [27] 16 2 (13) 2 2 (100) 0 (0) 1 1 0 (0)
Both pancreatitis and postoperative
Zyromski et al. [3] 37 1 (3) 1 1 (100) 0 (0) 1 1 (100)
Kalva et al. [1] 23 0 (0) – – –
Emb embolisation, Emerg emergency surgery, Isch fear of ischaemia, Stent vascular stent, Sur surgical management, No no management
a Technical failure includes inability to access or visualise vessel on angiogram and other technical reasons for failure of angioembolisation
b Number of failures/rebleeds unclear from paper. This is the best estimate from text
c Operative management was standard treatment at the time
Surg Endosc (2014) 28:2027–2038 2033
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[34]. Intra-arterial infusion of vasopressin as another
radiological treatment option for pseudoaneurysms arising
from the SMA has been described with a successful out-
come [13]. However, treating a structural anatomical
abnormality with a temporary vasospasm agent would
seem inadequate.
Rebleeding and the role of definitive surgery
Rebleeding after embolisation can occur early or late. Early
failure may be due to technical problems (e.g., failure to
cannulate or localise the bleeding) or to complications
during the procedure (e.g., arterial perforation or dissection
by the catheter) [14]. From the data presented, a significant
proportion of patients rebled at a later date despite an initial
successful embolisation (Table 2). Given that the initiating
event of the pseudoaneurysm (pancreatic enzymes, local
inflammation, or anastomotic leaks) is not dealt with by
embolisation, it is likely that these factors contribute to the
late rebleeding. While some studies specifically reported
12- or 24-h rebleeding rates, there was great variation in
reporting, and in many cases it was difficult to discern
between a rebleeding episode and primary failure. When
rebleeding was reported, only a few studies provided
details about the timing of the bleed and the original pre-
sentation or associated pathology. Overall, however, it was
clear from the data available that the risk of rebleeding is
present days and even months after an initial successful
embolisation [14, 24, 30].
Although the data are heterogeneous, several interesting
observations can be made from the studies reviewed. First,
routine imaging within the first week of the initial embol-
isation often detects filling of a residual pseudoaneurysm.
Sethi et al. [27] used CT scan follow-up at 24 h and at
1 week. They observed contrast in the aneurysmal sac in
20 % (3/15) of their cases despite haemodynamic stability
and no clinical evidence of ongoing haemorrhage. The
presence of such a residual pseudoaneurysm may contrib-
ute to the risk of late bleeding despite apparent initial
successful haemostasis. Second, the underlying secondary
pathology such as a pseudocyst or a GIT anastomotic leak
may increase the risk of rebleeding. This may be related to
exposure of the vessels to degradative enzymes such as the
lipase-rich fluid in a pseudocyst. This was demonstrated in
a small study of patients with severe pancreatitis in which
there was a rebleeding rate of 40 % (2/5) with a pseudocyst
but only 20 % (1/5) in those without residual fluid col-
lections [23]. A similar relationship appears to be true also
in patients with pancreatitis. There were two studies in
which the underlying pathology was specifically treated at
or around the time the bleeding was controlled. In the study
by Gambiez et al. [37], definitive surgery was performed
on most patients at the time of the initial bleeding
presentation; this resulted in no rebleeding after a median
follow-up of 60 months. Udd et al. [25] treated all pseud-
ocysts endoscopically if they were still present at 6 months
and found no rebleeding at the 1-month follow-up.
Of course, there are delayed complications other than
rebleeding that can occur after initial control of the
bleeding pseudoaneurysm. They are related to the ongoing
pathology as well as foreign body (coils or stents) place-
ment. Carr et al. [38] described 3/16 patients with pan-
creatitis treated for a pseudoaneurysm who developed late
complications. One patient required drainage for an
infection of a thrombosed pseudocyst and two others had
problems with coil migration into the left and right hepatic
arteries, respectively, causing left lobar infarction in one.
This highlights the importance of investigating and treating
any associated pathology as well as dealing with the
bleeding pseudoaneurysm. These patients are often unsta-
ble and require prioritisation of treatment, usually by
controlling the bleeding first, resuscitation second, and then
a planned approach to fixing the precipitating pathology.
The timing of endoscopic or surgical management of a
pseudocyst, or operative intervention for an anastomotic
leak, is often difficult because of sepsis or malnutrition.
These patients are best managed in a tertiary institution by
a multidisciplinary team in a high-dependency or intensive
care environment.
Although embolisation has made a dramatic impact on
the management of acute bleeding from peripancreatic
pseudocysts, radiological management may only be a
bridge treatment for some patients. It would be ideal to
be able to distinguish a patient as being in one of three
groups at the time of presentation: those that can be
successfully treated with embolisation alone without the
risk of delayed rebleeding, those in whom embolisation
may provide only a bridge to possible further surgery,
and those who will require early endoscopic or surgical
intervention. A management classification of peripan-
creatic pseudoaneurysms is proposed, based on the fol-
lowing factors that are identified after appropriate
imaging (Table 4; Fig. 1A): (1) the vessel of origin, (2)
the presence or absence of communication with the GIT,
and (3) the presence or absence of pancreatic juice at the
bleeding site. The first factor influences the selection of
the initial haemostatic strategy (embolisation, stent, of
surgery), while the other two factors may influence the
decision for definitive endoscopic or surgical manage-
ment (Fig. 1B).
The arteries from which the pseudoaneurysm arises can
be classified into three groups:
1. type I arises from a minor artery but must be at least
5 mm away from its junction of origin from a type II
or III artery
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2. type II arises from a major artery that may be
sacrificed without physiological consequences (e.g.,
splenic and gastroduodenal arteries)
3. type III arises from a major artery that cannot be
sacrificed without significant consequences for the
patient (e.g., the SMA or the hepatic artery proper)
Pseudoaneurysms can be further subclassified into:
a. type A where there is no communication with the GIT
b. type B where there is a communication with the GIT
In type A, bleeding tends to be low volume, often cre-
ating a haematoma within a confined space. In the retro-
peritoneal space, the expanding haematoma results in rising
pressure, which usually compresses the bleeding site.
These patients may develop acute renal failure as a result
of an abdominal compartment syndrome [39]. In type B,
patients frequently have a sentinel bleed that may be fol-
lowed by a catastrophic haemorrhage. Acute bleeding can
be controlled by either embolisation or a stent, but these
patients possibly have a higher risk of rebleeding and
infection as a result of contamination from the GIT. A
more definitive surgical procedure to deal with the
pseudoaneurysm may need to be considered after haemo-
dynamic stabilisation with embolisation or an endovascular
stent. In patients in whom aneursymal coils and glue or an
endovascular stent is exposed to a significant amount of
GIT contents, the risk of infection could lead to rebleeding.
This risk of rebleeding has to be balanced against the risk
of surgical intervention. A long and narrow communication
in an elderly patient can be observed, while a short and
wide communication in young patient may need a more
definitive surgical approach.
We suggest a further subclassification according to
exposure to pancreatic juice:
i. type 1 is no exposure to pancreatic juice
ii. type 2 is exposure to pancreatic juice
In a type 2 pseudoaneurysm, enzymes within the pan-
creatic juice can chemically digest the artery wall. This
may lead to further pseudoaneurysm formation or a
breaking of the seal between the native arterial wall and the
stent or embolisation agent. Patients with a pseudoaneu-
rysm and pseudocyst following pancreatitis and endoscopic
transgastric drainage of a pseudocyst may convert type 2
Table 4 Distribution of artery origins of the pseudoaneurysms in each study
Bleeding point/feeding vessel (main vessel or branches of) Total with PA or bleeding pointa
SPA GDA/PDA CHA/PHA L/R/M HA SMA Other
Postoperative only
Okuno et al. [13] 0 (0) 3 (21) 0 (0) 8 (57) 1 (7) 2 (14) 14
Fujii et al. [12]* 2 (14) 5 (36) 2 (14) 4 (29) 1 (7) 0 (0) 14
Miura et al. [5] 0 (0) 6 (38) 4 (25) 2 (13) 4 (25) 0 (0) 16
Lee [15] 1 (4) 12 (48) 4(16) 5 (20) 1 (4) 2 (8) 25
Scha¨fer et al. [30] 4 (22) 2 (11) 7 (39) 3 (17) 1 (6) 1 (6) 18
Lee et al. [31] No data 27
Pancreatitis only
Gambiez et al. [37] 4 (29) 8 (57) 0(0) 0 (0) 0 (0) 1 (7) 14
De Perrot et al. [14] 6 (60) 3 (30) 0 (0) 0 (0) 0 (0) 1 (10) 10
Carr et al. [38] 3 (23) 9 (70) 0 (0) 0 (0) 1 (8) 0 (0) 13b
Beattie et al. [23] 3 (23) 8 (62) 0 (0) 0 (0) 0 (0) 2 (15) 13
Bergert et al. [11] 10 (27) 16 (43) 4 (11) 0 (0) 4 (11) 3 (8) 37
Zhou et al. [40] No data 19
Lermite et al. [16] 6 (35) 8 (47) 1 (6) 0 (0) 1 (6) 1 (6) 17
Udd et al. [25] 14 (42) 19 (58) 0 (0) 0 (0) 0 (0) 0 (0) 33
Sethi et al. [27] 7 (44) 3 (19) 3 (19) 0 (0) 0 (0) 3 (19) 16
Both pancreatitis and postoperative
Zyromski et al. [3] 14 (36) 15 (38) 5 (13) 0 (0) 3 (8) 2 (5) 39
Kalva et al. [1] 5 (21) 10 (42) 3 (13) 2 (8) 0 (0) 4 (17) 24
CHA common hepatic artery, GDA gastroduodenal artery, L/R/MHA left/right/middle hepatic artery, PA pseudoaneurysm, PDA pancreatodu-
odenal artery, PHA proper hepatic artery, SMA superior mesenteric artery, SPA splenic artery
a Some patients had multiple PA so the total number of PA may be different from the total number of patients in the study
b Three patients’ bleeding point unknown
* Three patients did not demonstrate pseudoaneurysm on angiogram but rather had extravasation in the area of the respective vessels
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into type B. Some of these patients then can be managed
conservatively while others may require more definitive
surgical management in the long run. The main cause of a
pseudoaneurysm following pancreatic surgery is pancreatic
fistula. In some patients with an ISGPF type C pancreatic
fistula [41] and a pseudoaneurysm, completion pancrea-
tectomy can salvage the situation [42]. Others may have to
be managed by diverting the pancreatic juice away from
the pseudoaneurysmal vessel.
In summary, peripancreatic pseudoaneurysms may be
classified by a combination of the above factors as sum-
marised in Table 5.
Conclusion
Peripancreatic pseudoaneurysm formation is a major
complication that can result following pancreatobiliary
surgery or pancreatitis. It is frequently associated with
significant morbidity and mortality. Patients who form a
peripancreatic pseudoaneurysm are at high risk of reblee-
ding and often require a definitive surgical procedure after
bFig. 1 Top Examples of the proposed pseudoaneurysm classification
based upon the artery type (I–III), communication with GIT (A, B),
and exposure to pancreatic juice (1, 2). Bottom Further specific
examples of pseudoaneurysms arising after pancreatic surgery. A A
pseudoaneurysm originating from a short GDA stump may arise as a
result of a leak from the adjacent pancreatic anastomosis; this is a
type IIIB2 aneurysm. B Such a pseudoaneurysm, if it ruptures into the
anastomosis, will cause massive gastrointestinal bleeding. C Rupture
of a splenic artery pseudoaneurysm into a pseudocyst arising from a
pancreatic leak after distal pancreatectomy; this is a type IIA2
pseudoaneurysm
Table 5 Peripancreatic pseudoaneurysm classification system












II Major artery which
may be sacrificed
B Communication 2 Exposure
III Major artery which
cannot be sacrificed
Examples:
Splenic artery pseudoaneurysms (type II) arising from a pancreatic
pseudocyst (type 2) with no communication with GIT (type A) are
classified as type IIA2 pseudoaneurysm
A GDA stump (\5 mm) pseudoaneurysm arising from an area of
enteropancreatic leak is classified as a type IIIB2 pseudoaneurysm.
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initial radiological control by embolisation or placement of
a stent. Clinicians need to be aware of the risk of reblee-
ding at the onset of treatment as this can have a significant
impact on the definitive treatment strategy. We propose
that the risk of rebleeding depends on infection and
chemical digestion. The former is often due to communi-
cation with the GIT and the latter is caused by direct
contact between the arterial wall and pancreatic juice. The
management of this condition is usually a combination of
radiology, endoscopy, and surgery and this combination
may be assisted by a logical classification system.
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